Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance
RM Tuttle, JA Fagin, G Minkowitz… - … –Head & Neck …, 2017 - jamanetwork.com
… of low-risk papillary thyroid cancers in patients undergoing … low-risk papillary thyroid cancer,
most cancers remained stable … with papillary thyroid cancer undergoing active surveillance. …
most cancers remained stable … with papillary thyroid cancer undergoing active surveillance. …
Lymph node ratio predicts recurrence in papillary thyroid cancer
… Lymph node metastasis occurs in 20%–50% of patients presenting for initial treatment of
papillary thyroid cancer (PTC). The significance of lymph node metastases remains …
papillary thyroid cancer (PTC). The significance of lymph node metastases remains …
Current thyroid cancer trends in the United States
… We believe the time has come to address the problem of papillary thyroid cancer
overdiagnosis and overtreatment. Providing patients with randomized clinical trial data on an …
overdiagnosis and overtreatment. Providing patients with randomized clinical trial data on an …
Central lymph node dissection as a secondary procedure for papillary thyroid cancer: is there added morbidity?
R Alvarado, MS Sywak, L Delbridge, SB Sidhu - Surgery, 2009 - Elsevier
… Routine central lymph node dissection (CLND) for papillary thyroid cancer at the time of
initial thyroidectomy is now generally advocated. Our unit has demonstrated previously a …
initial thyroidectomy is now generally advocated. Our unit has demonstrated previously a …
Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption
MA Rossing, KL Cushing, LF Voigt, KG Wicklund… - …, 2000 - journals.lww.com
… thyroid cancer. Both smoking and alcohol consumption may influence TSH levels or activity
as well as thyroid … case-control study of papillary thyroid cancer in women, we examined the …
as well as thyroid … case-control study of papillary thyroid cancer in women, we examined the …
Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors
HR Nieto, CEM Thornton, K Brookes… - The Journal of …, 2022 - academic.oup.com
… Bioinformatic interrogation of available datasets revealed that at the time of investigation 46
of 501 reported papillary thyroid cancers (PTC) had recurred; our appraisal of gene mutation…
of 501 reported papillary thyroid cancers (PTC) had recurred; our appraisal of gene mutation…
Changing the Cancer Diagnosis: The Case of Follicular Variant of Papillary Thyroid Cancer—Primum Non Nocere and NIFTP
S Hodak, RM Tuttle, G Maytal, YE Nikiforov… - Thyroid, 2016 - liebertpub.com
… thyroid cancer, we may often be violating the important dictum primum non nocere. The financial
and emotional costs of thyroid cancer … that patients with thyroid cancer were significantly …
and emotional costs of thyroid cancer … that patients with thyroid cancer were significantly …
Cost‐effectiveness analysis of papillary thyroid cancer surveillance
LY Wang, BR Roman, JC Migliacci, FL Palmer… - Cancer, 2015 - Wiley Online Library
BACKGROUND The recent overdiagnosis of subclinical, low‐risk papillary thyroid cancer (PTC)
coincides with a growing national interest in cost‐effective health care practices. The …
coincides with a growing national interest in cost‐effective health care practices. The …
Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers
SR Rajjoub, H Yan, NA Calcatera, K Kuchta… - Surgery, 2018 - Elsevier
… Cancer Data Base, we evaluated 33,816 adults undergoing surgery for papillary thyroid
cancer … Conventional and follicular-variant papillary thyroid cancers were divided into separate …
cancer … Conventional and follicular-variant papillary thyroid cancers were divided into separate …
… Prevalence of BRAF Mutations in Thyroid Cancer: Genetic Evidence for Constitutive Activation of the RET/PTC-RAS-BRAF Signaling Pathway in Papillary Thyroid …
Thyroid papillary cancers (PTCs) are associated with activating mutations of genes coding
for RET or TRK tyrosine kinase receptors, as well as of RAS genes. Activating mutations of …
for RET or TRK tyrosine kinase receptors, as well as of RAS genes. Activating mutations of …